Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-06 Bylund James SVP, Global Operations & IT Sale −360 $204.25 $74K 6,324
2021-03-16 Gebski Christine Sale −1,400 $196.88 $276K 37,140
2021-03-12 RYAN THOMAS F JR Director Gift −170 1,294
2021-03-12 Hunt Anthony Chief Executive Officer Sale −914 $188.06 $172K 220,950
2021-03-12 Hunt Anthony Chief Executive Officer Sale −1,171 $188.77 $221K 219,779
2021-03-12 Hunt Anthony Chief Executive Officer Sale −4,096 $190.17 $779K 215,683
2021-03-12 Hunt Anthony Chief Executive Officer Sale −1,081 $191.19 $207K 214,602
2021-03-12 Hunt Anthony Chief Executive Officer Sale −1,378 $192.17 $265K 213,224
2021-03-12 Hunt Anthony Chief Executive Officer Sale −227 $193.30 $44K 212,997
2021-03-12 Hunt Anthony Chief Executive Officer Sale −235 $194.08 $46K 212,762
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion +2,000 $33.05 $66K 27,265
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion +5,850 $33.87 $198K 33,115
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion +150 $59.52 $9K 33,265
2021-03-10 KURIYEL RALF Senior VP, R&D Sale −6,354 $190.08 $1.2M 26,911
2021-03-10 KURIYEL RALF Senior VP, R&D Sale −642 $191.33 $123K 26,269
2021-03-10 KURIYEL RALF Senior VP, R&D Sale −1,004 $192.13 $193K 25,265
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −2,000 2,000
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −5,850 0
2021-03-10 KURIYEL RALF Senior VP, R&D Exercise or conversion · Stock Option (Right to Buy) −150 3,911
2021-03-04 Hunt Anthony Chief Executive Officer Sale −794 $197.94 $157K 242,970

Page 29 of 42 · 832 trades